Related Experiment Videos
Propafenone--a new agent for the treatment of ventricular arrhythmias
1Department of Medicine, Medical College of Ohio, Toledo 43699.
The American Journal of the Medical Sciences
|October 1, 1989
Abstract:
Over the last several years a number of new and potent antiarrhythmic agents have been developed. One of these promising new drugs, propafenone hydrochloride (Rhythmol), will soon be available for use in this country. Although similar in some aspects to flecainide and encainide, the drug possesses some unique characteristics. The purpose of this review is to summarize the pharmacologic and physiologic effects of propafenone and to outline its clinical use.